Growth Metrics

Dare Bioscience (DARE) Gross Profit (2023 - 2025)

Dare Bioscience's Gross Profit history spans 3 years, with the latest figure at $727877.0 for Q4 2025.

  • For Q4 2025, Gross Profit rose 1400.41% year-over-year to $727877.0; the TTM value through Dec 2025 reached $734394.0, up 7406.07%, while the annual FY2025 figure was $734394.0, 7406.07% up from the prior year.
  • Gross Profit reached $727877.0 in Q4 2025 per DARE's latest filing, up from $2262.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.0 million in Q3 2023 to a low of -$55973.0 in Q4 2024.
  • Average Gross Profit over 3 years is $193797.6, with a median of $22438.0 recorded in 2024.
  • The largest YoY upside for Gross Profit was 1461.86% in 2025 against a maximum downside of 194.36% in 2025.
  • A 3-year view of Gross Profit shows it stood at $1.0 million in 2023, then tumbled by 105.6% to -$55973.0 in 2024, then skyrocketed by 1400.41% to $727877.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Gross Profit are $727877.0 (Q4 2025), $2262.0 (Q3 2025), and -$21172.0 (Q2 2025).